Menu
  • Join
  • Login
  • Contact
 

Search abstracts


VALUE AND LIMITATIONS OF CUTTING-EDGE SCIENCE (E.G, PHARMACOGENOMICS AND POPULATION PHARMACODYNAMIC ANALYSIS) TO PATIENT CARE HERE AND NOW

  • At: 2015 FIP Congress in Düsseldorf (Germany)
  • Type: Presentation
  • By: IEIRI, Ichiro (Kyushu University, Clinical Pharmacokinetics, Fukuoka, Japan)
  • Co-author(s): Ichiro Ieiri
  • Abstract:

    In my presentation, I will talk about utility of cutting-edge science, such as pharmacogenomic (PGx) information and population pharmacodynamic (PPD) analysis, at patient care. Currently in Japan, PGx is incorporated into patient care; for example, highly advanced medical treatment (HAMT). The HAMT is the Japanese medical system to provide high

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses